Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 5 6 2019
medline: 20 2 2020
entrez: 5 6 2019
Statut: ppublish

Résumé

Background and Purpose- After large-vessel intracranial occlusion, the fate of the ischemic penumbra, and ultimately final infarct volume, largely depends on tissue perfusion. In this study, we evaluated whether blood pressure reduction and sustained relative hypotension during endovascular thrombectomy are associated with infarct progression and functional outcome. Methods- We identified consecutive patients with large-vessel intracranial occlusion ischemic stroke who underwent mechanical thrombectomy at 2 comprehensive stroke centers. Intraprocedural mean arterial pressure (MAP) was monitored throughout the procedure. ΔMAP was calculated as the difference between admission MAP and lowest MAP during endovascular thrombectomy until recanalization. Sustained hypotension was measured as the area between admission MAP and continuous measurements of intraprocedural MAP (aMAP). Final infarct volume was measured using magnetic resonance imaging at 24 hours, and functional outcome was assessed using the modified Rankin Scale at discharge and 90 days. Associations with outcome were analyzed using linear and ordinal multivariable logistic regression. Results- Three hundred ninety patients (mean age 71±14 years, mean National Institutes of Health Stroke Scale score of 17) were included in the study; of these, 280 (72%) achieved Thrombolysis in Cerebral Infarction 2B/3 reperfusion. Eighty-seven percent of patients experienced MAP reductions during endovascular thrombectomy (mean 31±20 mm Hg). ΔMAP was associated with greater infarct growth ( P=0.036) and final infarct volume ( P=0.035). Mean ΔMAP among patients with favorable outcomes (modified Rankin Scale score, 0-2) was 20±21 mm Hg compared with 30±24 mm Hg among patients with poor outcome ( P=0.002). In the multivariable analysis, ΔMAP was independently associated with higher (worse) modified Rankin Scale scores at discharge (adjusted odds ratio per 10 mm Hg, 1.17; 95% CI, 1.04-1.32; P=0.009) and at 90 days (adjusted odds ratio per 10 mm Hg, 1.22; 95% CI, 1.07-1.38; P=0.003). The association between aMAP and outcome was also significant at discharge ( P=0.002) and 90 days ( P=0.001). Conclusions- Blood pressure reduction before recanalization is associated with larger infarct volumes and worse functional outcomes for patients affected by large-vessel intracranial occlusion stroke. These results underscore the importance of BP management during endovascular thrombectomy and highlight the need for further investigation of blood pressure management after large-vessel intracranial occlusion stroke.

Identifiants

pubmed: 31159701
doi: 10.1161/STROKEAHA.118.024286
pmc: PMC6787912
mid: NIHMS1528424
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1797-1804

Subventions

Organisme : NINR NIH HHS
ID : R01 NR018335
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107136
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107215
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS106513
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001862
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Stroke. 1981 Nov-Dec;12(6):723-5
pubmed: 6272455
Stroke. 2015 Sep;46(9):2678-80
pubmed: 26173727
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Int J Stroke. 2016 Dec;11(9):1045-1052
pubmed: 27405859
J Neurointerv Surg. 2014 May;6(4):270-5
pubmed: 23761479
Stroke. 1999 Aug;30(8):1538-41
pubmed: 10436097
Stroke. 2017 Jul;48(7):1869-1876
pubmed: 28432266
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
J Neurosurg Anesthesiol. 2014 Apr;26(2):95-108
pubmed: 24594652
Anesthesiology. 2012 Feb;116(2):396-405
pubmed: 22222475
Stroke. 2004 Nov;35(11 Suppl 1):2671-4
pubmed: 15459433
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
J Neurointerv Surg. 2017 Dec;9(12):1166-1172
pubmed: 27986846
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
AJNR Am J Neuroradiol. 2017 Feb;38(2):294-298
pubmed: 27811133
Radiology. 2016 Jun;279(3):888-97
pubmed: 27092472
Br J Anaesth. 2018 Jun;120(6):1287-1294
pubmed: 29793595
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Cerebrovasc Dis. 2015;39(2):144-50
pubmed: 25661277
J Neurointerv Surg. 2017 May;9(5):451-454
pubmed: 27117174
J Neurointerv Surg. 2016 Sep;8(9):883-8
pubmed: 26371294
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2011 Dec;42(12):3435-40
pubmed: 21980202
Neuroradiology. 2017 Jun;59(6):545-553
pubmed: 28540400
Stroke. 2010 Oct;41(10):2316-22
pubmed: 20829514
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012
J Neurointerv Surg. 2018 Feb;10(2):107-111
pubmed: 28404769
Stroke. 1983 May-Jun;14(3):332-41
pubmed: 6658900
Stroke. 2017 Sep;48(9):2621-2627
pubmed: 28794271

Auteurs

Nils H Petersen (NH)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Santiago Ortega-Gutierrez (S)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.
Division of Stroke and Neurointerventional Surgery, Department of Neurology, University of Iowa, IA (S.O.-G., G.V.L., B.Z.-L., S.D.).

Anson Wang (A)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Gloria V Lopez (GV)

Division of Stroke and Neurointerventional Surgery, Department of Neurology, University of Iowa, IA (S.O.-G., G.V.L., B.Z.-L., S.D.).

Sumita Strander (S)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Sreeja Kodali (S)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Andrew Silverman (A)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Binbin Zheng-Lin (B)

Division of Stroke and Neurointerventional Surgery, Department of Neurology, University of Iowa, IA (S.O.-G., G.V.L., B.Z.-L., S.D.).

Sudeepta Dandapat (S)

Division of Stroke and Neurointerventional Surgery, Department of Neurology, University of Iowa, IA (S.O.-G., G.V.L., B.Z.-L., S.D.).

Lauren H Sansing (LH)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Joseph L Schindler (JL)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Guido J Falcone (GJ)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Emily J Gilmore (EJ)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Hardik Amin (H)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Branden Cord (B)

Department of Neurosurgery (B.C., R.M.H., C.M.), Yale University School of Medicine, New Haven, CT.

Ryan M Hebert (RM)

Department of Neurosurgery (B.C., R.M.H., C.M.), Yale University School of Medicine, New Haven, CT.

Charles Matouk (C)

Department of Neurosurgery (B.C., R.M.H., C.M.), Yale University School of Medicine, New Haven, CT.

Kevin N Sheth (KN)

From the Department of Neurology (N.H.P., A.W., S.S., S.K., A.S., L.H.S., J.L.S., G.J.F., E.J.G., H.A., K.N.S.), Yale University School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH